Iproniazid is an orally active, irreversible, non-selective monoamine oxidase (MAO) inhibitor. Iproniazid inhibits MAO activity and enhances Rotenone (HY-B1756)-induced Apoptosis. Iproniazid modulates neurotransmitter levels, affects neuronal function, induces hepatic necrosis, and interferes with the endocrine system. Iproniazid can be used in the research of depression, Parkinsons disease, and hepatotoxicity[1][2][3][4][5][6][7].
Molecular Weight:
179.22
Purity:
99.91
CAS Number:
[54-92-2]
Formula:
C9H13N3O
Target:
Apoptosis,Monoamine Oxidase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
